TY - JOUR
T1 - Neutron Radiation Dose Measurements in a Scanning Proton Therapy Room
T2 - Can Parents Remain Near Their Children During Treatment?
AU - Mares, Vladimir
AU - Farah, Jad
AU - De Saint-Hubert, Marijke
AU - Domański, Szymon
AU - Domingo, Carles
AU - Dommert, Martin
AU - Kłodowska, Magdalena
AU - Krzempek, Katarzyna
AU - Kuć, Michał
AU - Martínez-Rovira, Immaculada
AU - Michaś, Edyta
AU - Mojżeszek, Natalia
AU - Murawski, Łukasz
AU - Ploc, Ondrej
AU - Romero-Expósito, Maite
AU - Tisi, Marco
AU - Trompier, François
AU - Van Hoey, Olivier
AU - Van Ryckeghem, Laurent
AU - Wielunski, Marek
AU - Harrison, Roger M.
AU - Stolarczyk, Liliana
AU - Olko, Pawel
N1 - Publisher Copyright:
Copyright © 2022 Mares, Farah, De Saint-Hubert, Domański, Domingo, Dommert, Kłodowska, Krzempek, Kuć, Martínez-Rovira, Michaś, Mojżeszek, Murawski, Ploc, Romero-Expósito, Tisi, Trompier, Van Hoey, Van Ryckeghem, Wielunski, Harrison, Stolarczyk and Olko.
PY - 2022/7/14
Y1 - 2022/7/14
N2 - Purpose: This study aims to characterize the neutron radiation field inside a scanning proton therapy treatment room including the impact of different pediatric patient sizes. Materials and Methods: Working Group 9 of the European Radiation Dosimetry Group (EURADOS) has performed a comprehensive measurement campaign to measure neutron ambient dose equivalent, H*(10), at eight different positions around 1-, 5-, and 10-year-old pediatric anthropomorphic phantoms irradiated with a simulated brain tumor treatment. Several active detector systems were used. Results: The neutron dose mapping within the gantry room showed that H*(10) values significantly decreased with distance and angular deviation with respect to the beam axis. A maximum value of about 19.5 µSv/Gy was measured along the beam axis at 1 m from the isocenter for a 10-year-old pediatric phantom at 270° gantry angle. A minimum value of 0.1 µSv/Gy was measured at a distance of 2.25 m perpendicular to the beam axis for a 1-year-old pediatric phantom at 140° gantry angle. The H*(10) dependence on the size of the pediatric patient was observed. At 270° gantry position, the measured neutron H*(10) values for the 10-year-old pediatric phantom were up to 20% higher than those measured for the 5-year-old and up to 410% higher than for the 1-year-old phantom, respectively. Conclusions: Using active neutron detectors, secondary neutron mapping was performed to characterize the neutron field generated during proton therapy of pediatric patients. It is shown that the neutron ambient dose equivalent H*(10) significantly decreases with distance and angle with respect to the beam axis. It is reported that the total neutron exposure of a person staying at a position perpendicular to the beam axis at a distance greater than 2 m from the isocenter remains well below the dose limit of 1 mSv per year for the general public (recommended by the International Commission on Radiological Protection) during the entire treatment course with a target dose of up to 60 Gy. This comprehensive analysis is key for general neutron shielding issues, for example, the safe operation of anesthetic equipment. However, it also enables the evaluation of whether it is safe for parents to remain near their children during treatment to bring them comfort. Currently, radiation protection protocols prohibit the occupancy of the treatment room during beam delivery.
AB - Purpose: This study aims to characterize the neutron radiation field inside a scanning proton therapy treatment room including the impact of different pediatric patient sizes. Materials and Methods: Working Group 9 of the European Radiation Dosimetry Group (EURADOS) has performed a comprehensive measurement campaign to measure neutron ambient dose equivalent, H*(10), at eight different positions around 1-, 5-, and 10-year-old pediatric anthropomorphic phantoms irradiated with a simulated brain tumor treatment. Several active detector systems were used. Results: The neutron dose mapping within the gantry room showed that H*(10) values significantly decreased with distance and angular deviation with respect to the beam axis. A maximum value of about 19.5 µSv/Gy was measured along the beam axis at 1 m from the isocenter for a 10-year-old pediatric phantom at 270° gantry angle. A minimum value of 0.1 µSv/Gy was measured at a distance of 2.25 m perpendicular to the beam axis for a 1-year-old pediatric phantom at 140° gantry angle. The H*(10) dependence on the size of the pediatric patient was observed. At 270° gantry position, the measured neutron H*(10) values for the 10-year-old pediatric phantom were up to 20% higher than those measured for the 5-year-old and up to 410% higher than for the 1-year-old phantom, respectively. Conclusions: Using active neutron detectors, secondary neutron mapping was performed to characterize the neutron field generated during proton therapy of pediatric patients. It is shown that the neutron ambient dose equivalent H*(10) significantly decreases with distance and angle with respect to the beam axis. It is reported that the total neutron exposure of a person staying at a position perpendicular to the beam axis at a distance greater than 2 m from the isocenter remains well below the dose limit of 1 mSv per year for the general public (recommended by the International Commission on Radiological Protection) during the entire treatment course with a target dose of up to 60 Gy. This comprehensive analysis is key for general neutron shielding issues, for example, the safe operation of anesthetic equipment. However, it also enables the evaluation of whether it is safe for parents to remain near their children during treatment to bring them comfort. Currently, radiation protection protocols prohibit the occupancy of the treatment room during beam delivery.
KW - active neutron monitors
KW - ambient dose equivalent
KW - anthropomorphic pediatric phantom
KW - clinical conditions
KW - scanning proton therapy
KW - secondary neutrons
UR - http://www.scopus.com/inward/record.url?scp=85135010232&partnerID=8YFLogxK
U2 - 10.3389/fonc.2022.903706
DO - 10.3389/fonc.2022.903706
M3 - Article
C2 - 35912238
AN - SCOPUS:85135010232
SN - 2234-943X
VL - 12
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 903706
ER -